EXOZ CIK: 2010788

eXoZymes Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−1.18
FY24:
−8.51
FY25:
−6.50
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−0.31
FY24:
−0.36
FY25:
−0.15
Change from FY21 to FY25
millions USD
FY21:
2.31
FY22:
1.36
FY23:
1.00
FY24:
18.5
FY25:
−0.03
millions USD
FY21:
–
FY22:
–
FY23:
−0.49
FY24:
9.65
FY25:
−6.68
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.01
FY22:
−1.44
FY23:
−1.47
FY24:
−8.90
FY25:
−6.67

All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data